DE602004027127D1 - TREATMENT OF ASPERGILLUS INFECTIONS WITH THYMOSINE ALPHA 1 - Google Patents
TREATMENT OF ASPERGILLUS INFECTIONS WITH THYMOSINE ALPHA 1Info
- Publication number
- DE602004027127D1 DE602004027127D1 DE602004027127T DE602004027127T DE602004027127D1 DE 602004027127 D1 DE602004027127 D1 DE 602004027127D1 DE 602004027127 T DE602004027127 T DE 602004027127T DE 602004027127 T DE602004027127 T DE 602004027127T DE 602004027127 D1 DE602004027127 D1 DE 602004027127D1
- Authority
- DE
- Germany
- Prior art keywords
- treatment
- aspergillus infections
- thymosine
- alpha
- thymosine alpha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 201000002909 Aspergillosis Diseases 0.000 title 1
- 208000036641 Aspergillus infections Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45791103P | 2003-03-28 | 2003-03-28 | |
PCT/US2004/009550 WO2004087067A2 (en) | 2003-03-28 | 2004-03-29 | Treatment of aspergillus infections with thymosin alpha 1 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004027127D1 true DE602004027127D1 (en) | 2010-06-24 |
Family
ID=33131730
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004027127T Expired - Lifetime DE602004027127D1 (en) | 2003-03-28 | 2004-03-29 | TREATMENT OF ASPERGILLUS INFECTIONS WITH THYMOSINE ALPHA 1 |
Country Status (5)
Country | Link |
---|---|
CN (1) | CN100342907C (en) |
CY (1) | CY1110218T1 (en) |
DE (1) | DE602004027127D1 (en) |
ES (1) | ES2345552T3 (en) |
PT (1) | PT1613340E (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2826875A1 (en) * | 2011-02-09 | 2012-08-16 | Sciclone Pharmaceuticals, Inc. | Thymosin alpha peptide for preventing, reducing the severity of, and treating infection |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW224053B (en) * | 1991-09-13 | 1994-05-21 | Paul B Chretien |
-
2004
- 2004-03-29 PT PT04749495T patent/PT1613340E/en unknown
- 2004-03-29 CN CNB2004800084904A patent/CN100342907C/en not_active Expired - Lifetime
- 2004-03-29 ES ES04749495T patent/ES2345552T3/en not_active Expired - Lifetime
- 2004-03-29 DE DE602004027127T patent/DE602004027127D1/en not_active Expired - Lifetime
-
2010
- 2010-07-22 CY CY20101100691T patent/CY1110218T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
PT1613340E (en) | 2010-08-19 |
ES2345552T3 (en) | 2010-09-27 |
CN1767847A (en) | 2006-05-03 |
CY1110218T1 (en) | 2015-01-14 |
CN100342907C (en) | 2007-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE512163T1 (en) | ADMINISTRATION OF AGENTS FOR THE TREATMENT OF INFLAMMATION | |
DE60322582D1 (en) | SURFACE TREATMENT OF MEDICAL DEVICE | |
DE60001421D1 (en) | EXHAUST TREATMENT | |
ATE308997T1 (en) | AGENTS FOR THE TREATMENT OF DISEASES OF THE ESOPHAUS | |
DE60328476D1 (en) | MEDICAL BALLOON SYSTEM FOR THE TREATMENT OF ADIPOSITAS | |
DE50206657D1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MULTIPLE SCLEROSIS | |
ATE305306T1 (en) | REBOXETINE FOR THE TREATMENT OF PERIPHERAL NEUROPATHIES | |
DE60124302D1 (en) | THIAZONE DERIVATIVES FOR THE TREATMENT OF PPAR-LIFE DISEASES | |
EE05507B1 (en) | Use of rosuvastatin ZD4522) in the treatment of heterosgococcal family h percolesterolemia | |
DE50214540D1 (en) | PUNCH IN THE TREATMENT OF WOUNDS | |
DE602004010708D1 (en) | IMIDAZOPYRIDINE-SUBSTITUTED TROPANDERIVATES WITH CCR5-RECEPTORANTAGONISTIC EFFECT FOR THE TREATMENT OF HIV AND INFLAMMATION | |
DE60136477D1 (en) | RETINOIDES FOR THE TREATMENT OF EMPHYSEM | |
DE60136909D1 (en) | DRUGS WITH ANEMONIN AS ACTIVE FOR THE TREATMENT OF ASEPTIAN INFLAMMATION | |
FR2834459B1 (en) | MICROBICIDE AGENT AND COSMETIC TREATMENT COMPOSITION CONTAINING THE SAME | |
DE60325353D1 (en) | TREATMENT OF MUCOSITIS | |
DE60223576D1 (en) | SKIN TREATMENT COMPOSITION | |
DE50013843D1 (en) | MEDICAMENT FOR THE TREATMENT OF DARMER DISEASES | |
DE602004004262D1 (en) | ULTRASOUND TREATMENT OF GEWEBEMATRICES | |
DE60222664D1 (en) | SKIN TREATMENT AGENT | |
DE60103685D1 (en) | Treatment of poriomania | |
ATE253578T1 (en) | OXAZINOQUINOLONES FOR THE TREATMENT OF VIRAL INFECTIONS | |
ATE369136T1 (en) | THERAPEUTIC TREATMENT | |
ATE347888T1 (en) | USE OF AIVLOSIN FOR THE TREATMENT AND PREVENTION OF LAWSONIA INFECTIONS IN PIGS. | |
DE60110748D1 (en) | TREATMENT OF FLUOROEN CARBON FILLINGS | |
DE60120961D1 (en) | DISULFIDE DERIVATIVES USE FOR THE TREATMENT OF ALLERGIC DISEASES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |